SARAH MCCREA: Open Payments
NPI 1275061228 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 32 payments from 16 companies in 2025. Trend: 2023 $290 · 2024 $814 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| ABBVIE INC. | 3 | $76 |
| PFIZER INC. | 3 | $74 |
| Daiichi Sankyo Inc. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Eisai Inc. | 2 | $29 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: EPKINLY, IBRANCE, Enhertu, RYBREVANT, TECVAYLI, LIBTAYO, DARZALEX, Lenvima.
Industry payments across GA — which companies pay providers there.
